National Teaching Demonstration Center, School of Basic Medicine, Air Force Medical University (Fourth Military Medical University), Xi'an, 710032, China.
State Key Laboratory of Military Stomatology, School of Stomatology, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Mol Neurobiol. 2024 Feb;61(2):1119-1139. doi: 10.1007/s12035-023-03607-1. Epub 2023 Sep 9.
Although uncoupling protein 4 (UCP4) is the most abundant protein reported in the brain, the biological function of UCP4 in cerebellum and pathological outcome of UCP4 deficiency in cerebellum remain obscure. To evaluate the role of Ucp4 in the cerebellar Purkinje cells (PCs), we generated the conditional knockdown of Ucp4 in PCs (Pcp2;Ucp4 mice) by breeding Ucp4 mice with Pcp2 mice. Series results by Western blot, immunofluorescent staining, and triple RNAscope in situ hybridization confirmed the specific ablation of Ucp4 in PCs in Pcp2;Ucp4 mice, but did not affect the expression of Ucp2, the analog of Ucp4. Combined behavioral tests showed that Pcp2;Ucp4 mice displayed a characteristic bradykinesia in the spontaneous movements. The electromyogram recordings detection excluded the possibility of hypotonia in Pcp2;Ucp4 mice. And the electrical patch clamp recordings showed the altered properties of PCs in Pcp2;Ucp4 mice. Moreover, transmission electron microscope (TEM) results showed the increased mitochondrial circularity in PCs; ROS probe imaging showed the increased ROS generation in molecular layer; and finally, microplate reader assay showed the significant changes of mitochondrial functions, including ROS, ATP, and MMP in the isolated cerebellum tissue. The results suggested that the specific knockdown of mitochondrial protein Ucp4 could damage PCs possibly by attacking their mitochondrial function. The present study is the first to report a close relationship between UCP4 deletion with PCs impairment, and suggests the importance of UCP4 in the substantial support of mitochondrial function homeostasis in bradykinesia. UCP4 might be a therapeutic target for the cerebellar-related movement disorder.
虽然解偶联蛋白 4(UCP4)是大脑中报道最多的蛋白质,但 UCP4 在小脑中的生物学功能以及 UCP4 缺乏在小脑中的病理后果仍不清楚。为了评估 Ucp4 在小脑浦肯野细胞(PCs)中的作用,我们通过将 Ucp4 小鼠与 Pcp2 小鼠杂交,生成了条件性敲低 PCs 中 Ucp4 的小鼠(Pcp2;Ucp4 小鼠)。Western blot、免疫荧光染色和三重 RNAscope 原位杂交的一系列结果证实了 Pcp2;Ucp4 小鼠中 PCs 中 Ucp4 的特异性缺失,但不影响 Ucp2 的表达,Ucp2 是 Ucp4 的类似物。综合行为测试表明,Pcp2;Ucp4 小鼠在自发运动中表现出特征性的运动迟缓。肌电图记录检测排除了 Pcp2;Ucp4 小鼠出现张力减退的可能性。电膜片钳记录显示 Pcp2;Ucp4 小鼠中 PCs 的特性发生了改变。此外,透射电子显微镜(TEM)结果显示 PCs 中的线粒体圆形度增加;ROS 探针成像显示分子层中 ROS 生成增加;最后,微孔板读取器测定显示分离的小脑组织中线粒体功能的显著变化,包括 ROS、ATP 和 MMP。结果表明,线粒体蛋白 Ucp4 的特异性敲低可能通过攻击其线粒体功能来损伤 PCs。本研究首次报道了 UCP4 缺失与 PCs 损伤之间的密切关系,并表明 UCP4 在维持运动迟缓时线粒体功能内稳态方面的重要性。UCP4 可能是治疗与小脑相关的运动障碍的靶点。